China’s CDC admits: homegrown Coronavirus vaccine effectiveness low

The Associated Press, Nexstar Media Wire via Fox 21 News ^ | 04/11/2021

[SeekAndFind]

BEIJING (AP) — In a rare admission of the weakness of Chinese coronavirus vaccines, the country’s top disease control official says their effectiveness is low and the government is considering mixing them to get a boost.

Chinese vaccines “don’t have very high protection rates,” said the director of the China Centers for Disease Control, Gao Fu, at a conference Saturday in the southwestern city of Chengdu.

Beijing has distributed hundreds of millions of doses abroad while trying to promote doubt about the effectiveness of the Pfizer-BioNTech vaccine made using the previously experimental messenger RNA, or mRNA, process.

“It’s now under formal consideration whether we should use different vaccines from different technical lines for the immunization process,” Gao said.

Officials at a news conference Sunday didn’t respond directly to questions about Gao’s comment or possible changes in official plans. But another CDC official said developers are working on mRNA-based vaccines.

Gao did not respond to a phone call requesting further comment.

“The mRNA vaccines developed in our country have also entered the clinical trial stage,” said the official, Wang Huaqing. He gave no timeline for possible use.

Experts say mixing vaccines, or sequential immunization, might boost effectiveness. Researchers in Britain are studying a possible combination of Pfizer-BioNTech and the traditional AstraZeneca vaccine.

The coronavirus pandemic, which began in central China in late 2019, marks the first time the Chinese drug industry has played a role in responding to a global health emergency.

Vaccines made by Sinovac, a private company, and Sinopharm, a state-owned firm, have made up the majority of Chinese vaccines distributed to several dozen countries including Mexico, Turkey, Indonesia, Hungary, Brazil and Turkey.

[SeekAndFind]

FOR THOSE WHO WANT TO KNOW THE DETAILS:

* The effectiveness of a Sinovac vaccine at preventing symptomatic infections was found to be as low as 50.4% by researchers in Brazil, near the 50% threshold at which health experts say a vaccine is useful. By comparison, the Pfizer-BioNTech vaccine has been found to be 97% effective.

* Health experts say Chinese vaccines are unlikely to be sold to the United States, Western Europe and Japan due to the complexity of the approval process.

* A Sinovac spokesman, Liu Peicheng, acknowledged varying levels of effectiveness have been found but said that can be due to the age of people in a study, the strain of virus and other factors.

* Beijing has yet to approve any foreign vaccines for use in China.

[algore]

So it was the CCDC not the CDC, or is there even a difference I wonder?

[Flick Lives]

In a rare admission of the weakness of Chinese coronavirus vaccines, the country’s top disease control official says their effectiveness is low and the government is considering mixing them to get a boost.

—

In a communist system, “success” isn’t determined by the marketplace, but on providing the best bribes to government officials.

[JonPreston]

I need something that is effective against human variants.

[House Atreides]

“So it was the CCDC not the CDC, or is there even a difference I wonder?”
************************************************************
LOL - Not a whole lot of difference when it comes to advancing the interests of the CCP and the DNC aligned. Just IMHO, of course.

[I-ambush]

So they had to Operation Impulse Power.

[absalom01]

The leaky Sinovac jab is putting selective pressure on the virus, and that’s going to be a problem.

Better have a stockpile of Ivermectin, HCQ and Luvox on hand.

[CondoleezzaProtege]

Yes but what are the side effects of China’s shot? And does theirs at least stave off hospitalization and severe symptoms even if you get Covid?

It’s probably not as long lasting. But is it less taxing on the body overall?

[TBP]

do NOT let them have any of ours.